<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Conditioning including total body/lymphoid irradiation is widely used to prevent graft rejection in patients with refractory severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) undergoing hemopoietic cell transplantation (HCT) from alternative donors and or after graft manipulation </plain></SENT>
<SENT sid="1" pm="."><plain>To reduce regimen-related toxicity we transplanted three children with refractory SAA after conditioning with radiotherapy-free regimens </plain></SENT>
<SENT sid="2" pm="."><plain>Conditioning included fludarabine 175-180 mg/m2 in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, patient 1 (failing two previous grafts) received thiotepa 10 mg/kg and Campath-1H 60 mg/m2; patient 2 cyclophosphamide 120 mg/kg, thiotepa 15 mg/kg and OKT-3 0.1 mg/kg/day for 4 weeks; and patient 3 cyclophosphamide 120 and ATG 90 mg/kg </plain></SENT>
<SENT sid="4" pm="."><plain>Stem cell source was unmanipulated marrow from the same unrelated donor as for the two previous transplantations in patient 1 and CD34+-purified peripheral blood stem cells from an HLA-matched unrelated donor and from the haploidentical mother in patients 2 and 3 </plain></SENT>
<SENT sid="5" pm="."><plain>Only patient 1 received <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (GVHD) prophylaxis with <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> A and <z:chebi fb="0" ids="168396">mycophenolate</z:chebi> mofetil </plain></SENT>
<SENT sid="6" pm="."><plain>Follow-up is now 30, 51, and 15 months </plain></SENT>
<SENT sid="7" pm="."><plain>None of the patients developed GVHD </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients have <z:mpath ids='MPATH_458'>normal</z:mpath> counts with complete donor chimerism </plain></SENT>
<SENT sid="9" pm="."><plain>Fludarabine-based conditioning is powerfully immunosuppressive and may be used for children with refractory SAA undergoing HCT from alternative donors even after rejection following previous HCT </plain></SENT>
</text></document>